Janney Montgomery Scott LLC boosted its position in Perrigo Company plc (NYSE:PRGO - Free Report) by 39.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 90,624 shares of the company's stock after purchasing an additional 25,472 shares during the period. Janney Montgomery Scott LLC owned about 0.07% of Perrigo worth $2,330,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Versant Capital Management Inc acquired a new position in shares of Perrigo during the 4th quarter worth approximately $45,000. GAMMA Investing LLC increased its position in Perrigo by 93.7% during the fourth quarter. GAMMA Investing LLC now owns 1,920 shares of the company's stock worth $49,000 after buying an additional 929 shares in the last quarter. Central Pacific Bank Trust Division raised its holdings in shares of Perrigo by 33.3% in the fourth quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company's stock worth $51,000 after acquiring an additional 500 shares during the last quarter. Venturi Wealth Management LLC purchased a new stake in shares of Perrigo in the third quarter valued at $56,000. Finally, KBC Group NV boosted its stake in shares of Perrigo by 25.1% during the third quarter. KBC Group NV now owns 4,517 shares of the company's stock valued at $118,000 after acquiring an additional 905 shares during the last quarter. 95.91% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on PRGO. Argus downgraded shares of Perrigo from a "buy" rating to a "hold" rating in a research note on Tuesday, January 14th. Piper Sandler lowered Perrigo from an "overweight" rating to a "neutral" rating and reduced their price target for the stock from $34.00 to $27.00 in a research note on Monday, January 6th. Finally, StockNews.com downgraded Perrigo from a "buy" rating to a "hold" rating in a research report on Saturday, January 11th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Perrigo presently has an average rating of "Hold" and an average target price of $35.00.
Read Our Latest Report on PRGO
Perrigo Trading Down 0.0 %
Shares of PRGO stock traded down $0.01 on Wednesday, reaching $25.08. 848,329 shares of the stock were exchanged, compared to its average volume of 1,355,501. Perrigo Company plc has a 1-year low of $23.14 and a 1-year high of $33.46. The stock has a market cap of $3.42 billion, a P/E ratio of -21.44 and a beta of 0.54. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. The firm has a 50 day moving average of $25.81 and a two-hundred day moving average of $26.54.
Perrigo (NYSE:PRGO - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.81 earnings per share for the quarter, meeting the consensus estimate of $0.81. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The business had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.12 billion. During the same period in the previous year, the company posted $0.64 EPS. The company's revenue was down 3.2% compared to the same quarter last year. On average, research analysts anticipate that Perrigo Company plc will post 2.56 EPS for the current year.
Insider Buying and Selling at Perrigo
In other Perrigo news, Director Jeffrey B. Kindler sold 17,598 shares of the firm's stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $28.27, for a total value of $497,495.46. Following the transaction, the director now directly owns 5,409 shares of the company's stock, valued at $152,912.43. This trade represents a 76.49 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.40% of the stock is currently owned by corporate insiders.
Perrigo Profile
(
Free Report)
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
See Also

Before you consider Perrigo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.
While Perrigo currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.